CHEK1 and acute lymphoblastic leukemia: In this study we demonstrated that Chk1 functionality is fundamental for the survival of B-/T-ALL cell lines and primary cells, and that the inhibition of this kinase using, prexasertib, sensitized both cell lines and primary cells to the cytotoxicity of different compound normally used for the treatment of adult B-/T-ALL patients.